Literature DB >> 8415730

Expression of alpha-thymosins in human tissues in normal and abnormal growth.

O E Tsitsiloni1, J Stiakakis, A Koutselinis, J Gogas, C Markopoulos, P Yialouris, S Bekris, D Panoussopoulos, V Kiortsis, W Voelter.   

Abstract

Radioimmunoassays specific for the N and C termini of human prothymosin alpha and the N terminus of human parathymosin alpha were employed for the measurement of the levels of alpha-thymosins in human thymus, spleen, and liver during normal growth and intestine and breast in malignant growth. A differential expression of the two alpha-thymosins was observed in thymus (prothymosin alpha-rich) and liver (parathymosin alpha-rich). A decline in the levels of both alpha-thymosins was found with age, with prothymosin alpha in thymus showing the sharpest change (15- to 30-fold). The levels of both alpha-thymosins were higher in malignant tissues as compared with healthy ones. In breast cancer, in particular, the mean increase for prothymosin alpha and parathymosin alpha was 17.9- and 11.5-fold, respectively. The major crossreactive material was characterized in all cases as intact prothymosin alpha and parathymosin alpha. These results suggest an in vivo relationship of the expression of alpha-thymosins with the human tissue cell proliferation activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415730      PMCID: PMC47597          DOI: 10.1073/pnas.90.20.9504

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  A radioimmunoassay for parathymosin alpha using antibodies to synthetic N-terminal peptide 1-30.

Authors:  O E Tsitsiloni; P P Yialouris; E P Heimer; A M Felix; G P Evangelatos; C Soteriadis-Vlahos; J Stiakakis; E Hannappel; A A Haritos
Journal:  J Immunol Methods       Date:  1988-10-26       Impact factor: 2.303

2.  The identification of prothymosin alpha-like material in vertebrate lymphoid organs by a radioimmunoassay for the N-terminal decapeptide.

Authors:  P P Yialouris; G P Evangelatos; C Soteriadis-Vlahos; E P Heimer; A M Felix; O E Tsitsiloni; A A Haritos
Journal:  J Immunol Methods       Date:  1988-02-10       Impact factor: 2.303

3.  Prothymosin alpha and parathymosin: mRNA and polypeptide levels in rodent tissues.

Authors:  M Clinton; M Frangou-Lazaridis; C Panneerselvam; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1989-02-15       Impact factor: 4.013

4.  Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis.

Authors:  G J Reclos; C N Baxevanis; C Sfagos; C Papageorgiou; G C Tsokos; M Papamichail
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Prothymosin alpha restores the depressed autologous and allogeneic mixed lymphocyte responses in patients with systemic lupus erythematosus.

Authors:  C N Baxevanis; G J Reclos; M Papamichail; G C Tsokos
Journal:  Immunopharmacol Immunotoxicol       Date:  1987       Impact factor: 2.730

6.  Human prothymosin alpha: amino acid sequence and immunologic properties.

Authors:  L X Pan; A A Haritos; J Wideman; T Komiyama; M Chang; S Stein; S B Salvin; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1986-10       Impact factor: 4.013

7.  Prothymosin alpha in human blood.

Authors:  C Panneerselvam; A A Haritos; J Caldarella; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study.

Authors:  G G Steinmann; B Klaus; H K Müller-Hermelink
Journal:  Scand J Immunol       Date:  1985-11       Impact factor: 3.487

9.  The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA.

Authors:  W H Eschenfeldt; S L Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  The primary structure of rat parathymosin.

Authors:  T Komiyama; L X Pan; A A Haritos; J W Wideman; Y C Pan; M Chang; I Rogers; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more
  15 in total

1.  Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.

Authors:  M A Cotter; E S Robertson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells.

Authors:  Cheng-Der Wu; Yuan-Sung Kuo; Han-Chung Wu; Chin-Tarng Lin
Journal:  J Biomed Sci       Date:  2011-11-07       Impact factor: 8.410

3.  Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.

Authors:  Ruben N Karapetian; Alexandra G Evstafieva; Irina S Abaeva; Nina V Chichkova; Grigoriy S Filonov; Yuri P Rubtsov; Elena A Sukhacheva; Sergey V Melnikov; Ulrich Schneider; Erich E Wanker; Andrey B Vartapetian
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  Corticotropin-releasing factor-2 activation prevents gentamicin-induced oxidative stress in cells derived from the inner ear.

Authors:  Johnvesly Basappa; Sevin Turcan; Douglas E Vetter
Journal:  J Neurosci Res       Date:  2010-10       Impact factor: 4.164

5.  Novel small molecules relieve prothymosin alpha-mediated inhibition of apoptosome formation by blocking its interaction with Apaf-1.

Authors:  Xin Qi; Lai Wang; Fenghe Du
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

6.  Prothymosin alpha modulates the interaction of histone H1 with chromatin.

Authors:  Z Karetsou; R Sandaltzopoulos; M Frangou-Lazaridis; C Y Lai; O Tsolas; P B Becker; T Papamarcaki
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

7.  Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.

Authors:  Ranju Ralhan; Leroi V Desouza; Ajay Matta; Satyendra Chandra Tripathi; Shaun Ghanny; Siddartha Datta Gupta; Sudhir Bahadur; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2008-03-13       Impact factor: 5.911

8.  Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.

Authors:  Emmanual Unni; Frances S Kittrell; Uma Singh; Raghu Sinha
Journal:  Breast Cancer Res       Date:  2004-07-29       Impact factor: 6.466

9.  Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals.

Authors:  Cynthia de la Fuente; Francisco Santiago; Longwen Deng; Carolyne Eadie; Irene Zilberman; Kylene Kehn; Anil Maddukuri; Shanese Baylor; Kaili Wu; Chee Gun Lee; Anne Pumfery; Fatah Kashanchi
Journal:  BMC Biochem       Date:  2002-06-10       Impact factor: 4.059

10.  Differential gene expression in the brain of the African lungfish, Protopterus annectens, after six days or six months of aestivation in air.

Authors:  Kum C Hiong; Yuen K Ip; Wai P Wong; Shit F Chew
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.